Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2014 May 1.

Published in final edited form as: Clin Cancer Res. 2013 Mar 20;19(9):2442–2450. doi: 10.1158/1078-0432.CCR-12-3283

Table 3.

Correlation of clinicopathologic variables with PCA3 and TMPRSS2:ERG scores

			PCA3 Score		TMPRSS2:ERG Score
	Parameter	N	Median (95% CI)	p-value	Median (95% CI)	p-value
Family History	Yes	99	34 (26–43)	0.28^**	16 (8–25)	0.37^**
Family History	No	265	30 (27–35)	0.28^**	11 (7–15)	0.37^**
Clinical T-stage	T1	327	30 (27–34)	0.18^**	12 (8–15)	0.32^**
Clinical T-stage	T2	60	38 (28–49)	0.18^**	22 (3–48)	0.32^**
Gleason Score	no cancer detected	79	27 (24–31)	0.02^*	5 (2–8)	.001^*
	5 or 6	278	31 (27–35)		14 (9–18)
	≥7	30	48 (31–92)		29 (13–78)
Tumor Volume	no cancer detected	79	27 (24–31)	0.004^*	3 (2–8)	<0.0001^*
	1–10	112	28 (22–35)		10 (4–14)
	11–33	108	40 (31–51)		20 (14–31)
	≥34	19	46 (18–90)		27 (4–115)

^*

Kruskal-Wallis test,

^**

Mann-Whitney test